The <i>in vitro</i> activity of aztreonam-avibactam and cefiderocol against globally collected clinical metallo-β-lactamase- and/or serine-carbapenemase-positive Enterobacterales isolates and the utility of commonly used <i>in vitro</i> diagnostic ki
activity of aztreonam-avibactam, cefiderocol, and other comparator agents against isolates that were positive for carbapenemases.
Authors
- Shweta Kamat (ORCID: https://orcid.org/0000-0003-3584-5014)
- Andrew Ian Townsend
- Christina Streit
- Mark Estabrook
- Daniel Sahm
- Gregory Stone
Institutions
- Pfizer (United States) (US)
Publication Details
- Journal
- Microbiology Spectrum
- Published
- 2026-03-31
- DOI
- https://doi.org/10.1128/spectrum.03820-25
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer